Literature DB >> 32404702

68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma.

Ew-Jun Chen, Teik Hin Tan, Ming Tsuey Chew1, Ping Ching Chye2.   

Abstract

Recent case reports and series have demonstrated the usefulness of Ga/F-PSMA PET/CT in restaging recurrent renal cancer after nephrectomy. We presented a case of a patient with renal mass who had undergone both F-FDG and Ga-PSMA PET/CT for diagnosis and staging. Concordant tracer uptake in the primary tumor and metastatic lesions was demonstrated by both radiotracers. Final histopathological reports revealed clear cell renal cell carcinoma. Furthermore, unusual left metacarpal bone metastasis was also detected.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32404702     DOI: 10.1097/RLU.0000000000003053

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  PSMA-PET/CT in Patients with Recurrent Clear Cell Renal Cell Carcinoma: Histopathological Correlations of Imaging Findings.

Authors:  Falk Gühne; Philipp Seifert; Bernhard Theis; Matthias Steinert; Martin Freesmeyer; Robert Drescher
Journal:  Diagnostics (Basel)       Date:  2021-06-23

Review 2.  PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports.

Authors:  M J M Uijen; Y H W Derks; W A M van Gemert; J Nagarajah; R I J Merkx; M G M Schilham; J Roosen; B M Privé; S A M van Lith; C M L van Herpen; M Gotthardt; S Heskamp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-12       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.